Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study

Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study

Background COVID-19 is a worldwide pandemic caused by the highly infective SARS-CoV-2. There is a need for biomarkers not only for overall prognosis but also for predicting the response to treatments and thus for improvements in the clinical management of patients with COVID-19. Circulating cell-fre...

Full description

Bibliographic Details
Main Authors: Katharina Hoeter, Elmo Neuberger, Susanne Fischer, Manuel Herbst, Ema Juškevičiūtė, Kira Enders, Heidi Rossmann, Martin F. Sprinzl, Perikles Simon, Marc Bodenstein, Michael Schaefer
Format: Article
Language:English
Published: PeerJ Inc. 2023-09-01
Series:PeerJ
Subjects:
COVID-19
Sars-CoV-2
Cell free DNA
Organ dysfunction
Clinical outcome
Online Access:https://peerj.com/articles/16072.pdf

Internet

https://peerj.com/articles/16072.pdf

Similar Items